Currently out of the existing stock ratings of Anne Samuel, 71 are a BUY (61.74%), 38 are a HOLD (33.04%), 6 are a SELL (5.22%).

Anne Samuel

Work Performance Price Targets & Ratings Chart

Analyst Anne Samuel, carries an average stock price target met ratio of 65.8% that have a potential upside of 15.6% achieved within 222 days. Previously, Anne Samuel worked at JPMORGAN.

Anne Samuel’s has documented 238 price targets and ratings displayed on 21 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on HQY, HealthEquity at 03-Sep-2025.

Wall Street Analyst Anne Samuel

Analyst best performing recommendations are on OMCL (OMNICELL).
The best stock recommendation documented was for OMCL (OMNICELL) at 11/20/2024. The price target of $44 was fulfilled within 1 day with a profit of $2.18 (5.21%) receiving and performance score of 52.13.

Average potential price target upside

of $36.19 (19.89%) on IQV (IQVIA HOLDINGS).
of $30.53 (18.4%) on VEEV (VEEVA SYSTEMS).
of $15.44 (47.12%) on MD (MEDNAX).

EVH Evolent Health HQY HealthEquity MDRX Allscripts Healthcare Solutions PHR Phreesia NXGN Nextgen Healthcare PGNY Progyny RCM R1 RCM SGFY Signify Health SIG Signet Jewelers Ltd HCAT Health Catalyst CERN Cerner Corp OMCL Omnicell VEEV Veeva Systems IQV IQVIA Holdings LVGO Livongo Health CCSI Consensus Cloud Solutions PINC Premier DOCS Doximity ATHN athenahealth MD Mednax RC Ready Capital Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Jailendra Singh (TRUIST)